Gene: CNPY3
Official Full Name: canopy FGF signaling regulator 3provided by HGNC
Gene Summary: This gene encodes a protein that binds members of the toll-like receptor protein family and functions as a chaperone to aid in folding and export of these proteins. Alternative splicing results in multiple transcript variants. Naturally occuring readthrough transcription occurs between this locus and the downstream GNMT (glycine N-methyltransferase) gene and is represented with GeneID:107080644. [provided by RefSeq, Jan 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO31605 | CNPY3 Knockout cell line (HeLa) | Human | CNPY3 | 1:3~1:6 | Negative | Online Inquiry |
KO31606 | CNPY3 Knockout cell line (HCT 116) | Human | CNPY3 | 1:2~1:4 | Negative | Online Inquiry |
KO31607 | CNPY3 Knockout cell line (HEK293) | Human | CNPY3 | 1:3~1:6 | Negative | Online Inquiry |
KO31608 | CNPY3 Knockout cell line (A549) | Human | CNPY3 | 1:3~1:4 | Negative | Online Inquiry |
CNPY3 Gene Knockout Cell Lines are sophisticated biological tools designed for the study of cellular functions and pathways influenced by the CNPY3 gene. This particular gene encodes a protein implicated in various cellular processes, including development, stress responses, and potentially in the pathology of certain diseases. The knockout cell lines are engineered to entirely disable the expression of the CNPY3 gene, allowing researchers to delve into the gene's role in cellular physiology and its implications in disease mechanisms.
These cell lines function by utilizing CRISPR-Cas9 technology, which serves as a precise method for gene editing. By creating targeted disruptions in the CNPY3 gene, researchers can observe the resultant phenotypic changes and assess how the absence of CNPY3 affects cell signaling, proliferation, and survival. This approach not only provides insights into the gene's functional role but also aids in elucidating its potential involvement in pathological conditions such as cancer, metabolic disorders, or neurodegenerative diseases.
From a scientific standpoint, CNPY3 Gene Knockout Cell Lines are invaluable for both research and clinical applications. They facilitate the investigation of gene function in a controlled environment, which is critical for drug discovery, the validation of therapeutic targets, and understanding the biological underpinnings of diseases. Moreover, these cell lines can serve as a platform for assays, including high-throughput screening, thereby accelerating the pace of biomedical research.
Compared to traditional knockout methods, CNPY3 Gene Knockout Cell Lines offer higher specificity and efficiency, drastically reducing off-target effects and improving reproducibility in experiments. This precision enables researchers to draw more accurate conclusions, making these cell lines superior alternatives to less precise techniques.
For researchers and clinicians seeking to explore the intricate role of the CNPY3 gene, these knockout cell lines are a must-have resource. They empower researchers to contribute significantly to the advancement of medical science, potentially leading to groundbreaking therapies and interventions. Our company specializes in high-quality biological products, providing reliable tools and resources that stand at the forefront of innovation in genetic research and therapy development.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.